Faeth Therapeutics, Inc. (FTH) Tops Q2 EPS by 132c
Tweet
Share
E-mailGet Alerts FTH Hot Sheet
Join SI Premium – FREE
Faeth Therapeutics, Inc. (NASDAQ: FTH) reported Q2 EPS of ($2.84), $1.32 better than the analyst estimate of ($4.16).
For earnings history and earnings-related data on Faeth Therapeutics, Inc. (FTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Mercury Systems (MRCY) Misses Q4 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
